Interní Med. 2011; 13(5): 193-195

Outpatient management of venous thromboembolism

doc.MUDr.Radovan Malý, Ph.D., MUDr.Luděk Beran, MUDr.Tomáš Tomko
I. interní klinika LF UK a FN, subkatedra angiologie, Angiocentrum FN Hradec Králové

Venous thromboembolism (VTE) is a common and potentially fatal disease. There is growing evidence that outpatient therapy with low

molecular-weight heparin (LMWH) is effective and safe for many patients with VTE. Large, randomised, controlled trials have demonstrated

that outpatient treatment of deep vein thrombosis (DVT) with LMWH is as safe as the hospital-based treatment with intravenous

unfractiona ted heparin. However, the role of outpatient therapy in patients with pulmonary embolism (PE) is unclear and has been

a matter of debate in the literature.

Keywords: venous tromboembolism, deep vein thrombosis, pulmonary embolism, outpatient treatment, low molecular-weight heparin

Published: June 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Malý R, Beran L, Tomko T. Outpatient management of venous thromboembolism. Interní Med. 2011;13(5):193-195.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Roztočil K. Léčba žilní trombózy. In. Widimský J, Malý J, a kol. Akutní plicní embolie a žilní trombóza. Praha: Triton 2005: 149-173.
    2. Widimský J, Malý J. Akutní plicní embolie a žilní trombóza. 2. rozšířené a přepracované vydání. Praha: Triton 2005; 381.
    3. Karetová D. Antikoagulační léčba flebotrombóz v ambulantní praxi. Vnitř lék 2005; 51: 790-794.
    4. Partsch H. Bed rest versus ambulation in the initial treatment of patients with proximal deep vein thrombosis. Curr Opin Pulm Med 2002; 8: 389-393. Go to original source... Go to PubMed...
    5. Partsch H, Blattler W. Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin. J Vasc Surg 2000; 32: 861-869. Go to original source... Go to PubMed...
    6. Krčová V. Nízkomolekulární hepariny v ambulantní praxi při léčbě hluboké žilní trombózy. Med pro praxi 2007; 3: 102-104.
    7. Dolovich LR, Ginsberg JS, Douketis JD, et al. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Arch Intern Med 2000; 160: 181-188. Go to original source... Go to PubMed...
    8. Gould MK, Dembitzer AD, Doyle RL, et al. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis - A meta-analysis of randomized, controlled trials. Ann Intern Med 1999; 130: 800-809. Go to original source... Go to PubMed...
    9. Kearon C, Kahn SR, Agnelli G, et al. American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133(Suppl 6): 454S-545S. Go to original source...
    10. Boccalon H, Elias A, Chalé JJ, et al. Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin: the Vascular Midi-Pyrenees study. Arch Intern Med 2000; 160: 1769-1773. Go to original source... Go to PubMed...
    11. Koopman MM, Prandoni P, Piovella F, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med 1996; 334: 682-687. Go to original source... Go to PubMed...
    12. Levine M, Gent M, Hirsh J, et al. A comparison of lowmolecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996; 334: 677-681. Go to original source... Go to PubMed...
    13. The Columbus Investigators. Low molecular heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997; 337: 657-662. Go to original source... Go to PubMed...
    14. Baglin T. Fifty per cent of patients with pulmonary embolism can be treated as outpatients. J Thromb Haemost 2010; 8: 2404-2405. Go to original source... Go to PubMed...
    15. Erkens PMG, Gandara E, Wells P, et al. Safety of outpatient treatment in acute pulmonary embolism. J Thromb Haemost 2010; 8: 2412-2417. Go to original source... Go to PubMed...
    16. Kovacs MJ, Hawel JD, Rekman JF, Lazo-Langner A. Ambulatory management of pulmonary embolism: a pragmatic evaluation. J Thromb Haemost 2010; 8: 2406-2411. Go to original source... Go to PubMed...
    17. Kovacs MJ, Anderson D, Morrow B, et al. Outpatient treatment of pulmonary embolism with dalteparin. Thromb Haemost 2000; 83: 209-211. Go to original source... Go to PubMed...
    18. Maestre A, Sánchez R, Rosa V, et al. RIETE Investigators. Clinical characteristics and outcome of inpatients versus outpatients with venous thromboembolism: findings from the RIETE Registry. Eur J Intern Med 2010; 21: 377-382. Go to original source... Go to PubMed...
    19. Gould MK, Dembitzer AD, Sanders GD, Garber AM. Lowmolecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis. Ann Intern Med 1999; 130: 789-799. Go to original source... Go to PubMed...
    20. Malý J, Dulíček P, Pecka M, et al. Účinnost a bezpečnost ambulantní léčby hluboké žilní trombózy nadroparinem. Interní Med 2006; 3: 142-147.
    21. Lapidus L, Borretzen J, Fahlén M, et al. Home treatment of deep vein thrombosis. An out-patient treatment model with one daily injection of low-molecular-weight heparin (tinzaparin) in 555 patients. Patophysiol Haemost Tromb 2002; 32: 59-66. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.